Ó³»­´«Ã½

Researchers take a broad, multi-faceted look at a large collection of cancer cell lines, creating a new trove of data to explore for drug development opportunities.

Calculating genetic risk scores for obesity, new insights about leukemia drugs, and more.

Molecular clues to microbes and multiple cancers.

A systems biology look at how the human body changes after birth, key insights into cancer, investigating ancient Iberia, and more.

Single-cell genomics study reveals cell types relevant to disease progression, immune response suppression.

New map connects the dots in cellular reprogramming, genetic insights into sleep timing preferences, immune cells sorted with microfluidics and more.

Chordoma is literally a one in a million cancer, with few effective treatment options. A new understanding of the biology behind this tumor type is bringing novel opportunities to light.

Biopsies taken before and after treatment reveal new resistance route, as well as an opportunity to resensitize metastatic breast cancers to therapy.

Using a new model dubbed DEMETER2, the Ó³»­´«Ã½'s Cancer Dependency Map team has compiled the largest dataset of genetic dependencies in cancer to date.